Logo image of CTZ.CA

NAMSYS INC (CTZ.CA) Stock Fundamental Analysis

Canada - TSX-V:CTZ - CA6300001071 - Common Stock

1.38 CAD
-0.02 (-1.43%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

7

Overall CTZ gets a fundamental rating of 7 out of 10. We evaluated CTZ against 62 industry peers in the Software industry. Both the health and profitability get an excellent rating, making CTZ a very profitable company, without any liquidiy or solvency issues. CTZ has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CTZ had positive earnings in the past year.
In the past year CTZ had a positive cash flow from operations.
Of the past 5 years CTZ 4 years were profitable.
Of the past 5 years CTZ 4 years had a positive operating cash flow.
CTZ.CA Yearly Net Income VS EBIT VS OCF VS FCFCTZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M

1.2 Ratios

CTZ has a better Return On Assets (21.71%) than 93.55% of its industry peers.
CTZ has a Return On Equity of 23.80%. This is amongst the best in the industry. CTZ outperforms 91.94% of its industry peers.
CTZ's Return On Invested Capital of 21.30% is amongst the best of the industry. CTZ outperforms 95.16% of its industry peers.
CTZ had an Average Return On Invested Capital over the past 3 years of 20.76%. This is significantly above the industry average of 12.35%.
The 3 year average ROIC (20.76%) for CTZ is below the current ROIC(21.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 21.71%
ROE 23.8%
ROIC 21.3%
ROA(3y)20.74%
ROA(5y)14.37%
ROE(3y)23.07%
ROE(5y)12.84%
ROIC(3y)20.76%
ROIC(5y)24%
CTZ.CA Yearly ROA, ROE, ROICCTZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

CTZ's Profit Margin of 31.45% is amongst the best of the industry. CTZ outperforms 98.39% of its industry peers.
CTZ's Profit Margin has been stable in the last couple of years.
CTZ has a Operating Margin of 39.48%. This is amongst the best in the industry. CTZ outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of CTZ has declined.
CTZ's Gross Margin of 64.31% is fine compared to the rest of the industry. CTZ outperforms 70.97% of its industry peers.
In the last couple of years the Gross Margin of CTZ has remained more or less at the same level.
Industry RankSector Rank
OM 39.48%
PM (TTM) 31.45%
GM 64.31%
OM growth 3Y0.73%
OM growth 5Y-2.15%
PM growth 3Y6.28%
PM growth 5Y-0.63%
GM growth 3Y1.23%
GM growth 5Y-1.35%
CTZ.CA Yearly Profit, Operating, Gross MarginsCTZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

10

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CTZ is creating value.
CTZ has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CTZ has less shares outstanding
CTZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CTZ.CA Yearly Shares OutstandingCTZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CTZ.CA Yearly Total Debt VS Total AssetsCTZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 26.02 indicates that CTZ is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 26.02, CTZ belongs to the best of the industry, outperforming 95.16% of the companies in the same industry.
There is no outstanding debt for CTZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 26.02
ROIC/WACC2.01
WACC10.6%
CTZ.CA Yearly LT Debt VS Equity VS FCFCTZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 11.36 indicates that CTZ has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 11.36, CTZ belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
A Quick Ratio of 11.36 indicates that CTZ has no problem at all paying its short term obligations.
CTZ's Quick ratio of 11.36 is amongst the best of the industry. CTZ outperforms 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 11.36
Quick Ratio 11.36
CTZ.CA Yearly Current Assets VS Current LiabilitesCTZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

4

3. Growth

3.1 Past

CTZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.68%, which is quite impressive.
The Earnings Per Share has been growing by 9.78% on average over the past years. This is quite good.
CTZ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.05%.
The Revenue has been growing by 10.68% on average over the past years. This is quite good.
EPS 1Y (TTM)23.68%
EPS 3Y17.83%
EPS 5Y9.78%
EPS Q2Q%7.08%
Revenue 1Y (TTM)18.05%
Revenue growth 3Y11.2%
Revenue growth 5Y10.68%
Sales Q2Q%10.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTZ.CA Yearly Revenue VS EstimatesCTZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.33 indicates a correct valuation of CTZ.
Based on the Price/Earnings ratio, CTZ is valued cheaper than 88.71% of the companies in the same industry.
CTZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.35.
Industry RankSector Rank
PE 15.33
Fwd PE N/A
CTZ.CA Price Earnings VS Forward Price EarningsCTZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTZ indicates a rather cheap valuation: CTZ is cheaper than 91.94% of the companies listed in the same industry.
CTZ's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CTZ is cheaper than 82.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.64
EV/EBITDA 6.25
CTZ.CA Per share dataCTZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

CTZ has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.57
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CTZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NAMSYS INC

TSX-V:CTZ (10/10/2025, 7:00:00 PM)

1.38

-0.02 (-1.43%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-25 2025-09-25
Earnings (Next)02-17 2026-02-17
Inst Owners21.43%
Inst Owner ChangeN/A
Ins Owners8.17%
Ins Owner ChangeN/A
Market Cap37.15M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.33
Fwd PE N/A
P/S 4.81
P/FCF 17.64
P/OCF 17.56
P/B 3.64
P/tB 3.64
EV/EBITDA 6.25
EPS(TTM)0.09
EY6.52%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.08
FCFY5.67%
OCF(TTM)0.08
OCFY5.7%
SpS0.29
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)1.57
Profitability
Industry RankSector Rank
ROA 21.71%
ROE 23.8%
ROCE 29.87%
ROIC 21.3%
ROICexc 328.31%
ROICexgc 328.31%
OM 39.48%
PM (TTM) 31.45%
GM 64.31%
FCFM 27.27%
ROA(3y)20.74%
ROA(5y)14.37%
ROE(3y)23.07%
ROE(5y)12.84%
ROIC(3y)20.76%
ROIC(5y)24%
ROICexc(3y)454.3%
ROICexc(5y)N/A
ROICexgc(3y)454.3%
ROICexgc(5y)N/A
ROCE(3y)29.1%
ROCE(5y)33.64%
ROICexcg growth 3Y-15.99%
ROICexcg growth 5Y13.62%
ROICexc growth 3Y-15.99%
ROICexc growth 5Y13.62%
OM growth 3Y0.73%
OM growth 5Y-2.15%
PM growth 3Y6.28%
PM growth 5Y-0.63%
GM growth 3Y1.23%
GM growth 5Y-1.35%
F-Score5
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 132.88%
Cap/Sales 0.13%
Interest Coverage 250
Cash Conversion 69.23%
Profit Quality 86.71%
Current Ratio 11.36
Quick Ratio 11.36
Altman-Z 26.02
F-Score5
WACC10.6%
ROIC/WACC2.01
Cap/Depr(3y)76.27%
Cap/Depr(5y)51.64%
Cap/Sales(3y)0.13%
Cap/Sales(5y)0.16%
Profit Quality(3y)96.79%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.68%
EPS 3Y17.83%
EPS 5Y9.78%
EPS Q2Q%7.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.05%
Revenue growth 3Y11.2%
Revenue growth 5Y10.68%
Sales Q2Q%10.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.21%
EBIT growth 3Y12.01%
EBIT growth 5Y8.3%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.15%
FCF growth 3YN/A
FCF growth 5Y12.45%
OCF growth 1Y38.32%
OCF growth 3YN/A
OCF growth 5Y12.31%